<h1 id="remifentanil">Remifentanil</h1>
<h2 id="description">Description</h2>
<ul>
  <li>Ultra-short-acting synthetic opioid analgesic</li>
  <li>Used for pain management and as an adjunct to anesthesia</li>
  <li>Rapid onset and short duration of action</li>
</ul>
<h2 id="mechanism-of-action">Mechanism of Action</h2>
<ul>
  <li>Acts primarily on mu-opioid receptors in the brain and spinal cord</li>
  <li>Minimal or no activity on delta and kappa opioid receptors</li>
  <li>Rapidly metabolized by nonspecific esterases in blood and tissues</li>
</ul>
<h2 id="indications">Indications</h2>
<ul>
  <li>Induction and maintenance of general anesthesia</li>
  <li>Analgesia during short/intense surgical procedures</li>
  <li>MAC sparing agent</li>
</ul>
<h2 id="dosage">Dosage</h2>
<ul>
  <li><strong>Bolus:</strong>
    <ul>
      <li>1 µg/kg IV bolus</li>
    </ul>
  </li>
  <li><strong>Maintenance of anesthesia:</strong>
    <ul>
      <li>0.05 to 0.2 µg/kg/min IV infusion</li>
    </ul>
  </li>
  <li><strong>Analgesia during surgery:</strong>
    <ul>
      <li>0.5 to 1 µg/kg IV bolus</li>
      <li>Followed by an infusion of 0.05 to 0.2 µg/kg/min</li>
    </ul>
  </li>
</ul>
<h2 id="contraindications">Contraindications</h2>
<ul>
  <li>Hypersensitivity to remifentanil or any of its components</li>
  <li>Patients not receiving appropriate respiratory support</li>
</ul>
<h2 id="side-effects">Side Effects</h2>
<ul>
  <li>Bradycardia</li>
  <li>Respiratory depression</li>
  <li>Hypotension</li>
  <li>Muscle rigidity – particularly chest wall rigidity</li>
  <li>Nausea and vomiting</li>
</ul>
<h2 id="references">References</h2>
<ol>
  <li>
    <table>
      <tbody>
        <tr>
          <td>[[@cullenBarashCullenStoelting2024</td>
          <td>Bruce F. Cullen, Bruce F. Cullen, Barash, Cullen, and Stoelting's clinical anesthesia, 2024]]</td>
        </tr>
      </tbody>
    </table>
  </li>
</ol>